Bulgarian Court Clears 'Revival' Leader of COVID Panic Charges
Bulgaria's Sofia District Court has rendered a verdict, declaring Kostadin Kostadinov innocent of charges related to inciting fear and panic
EU countries can use Pfizer’s anti-viral pills – Paxlovid, to treat COVID-19 in the early stages of diagnosis, although the approval process is not yet complete, the EU's drug regulator said.
Patients at high risk of severe disease should start a five-day course of paxlovid as soon as possible after diagnosis or within 5 days of symptoms, but not if additional oxygen is needed, reads the opinion of the European Medicines Agency (EMA).
"The agency's board can now be used to support national recommendations for the possible use of the drug before a marketing authorization is granted," the statement said.
The EMA has previously allowed the use of some injectable antibody-based drugs in a similar way, and this is happening at a time when governments are rushing to strengthen their arsenal to fight Omicron. It is possible that the new coronavirus variant has already developed resistance to some of these drugs, Reuters notes.
Amid an increase in new coronavirus cases in Europe, the EMA made a similar decision last month for Merck's molnupivir pill. The agency advised that it be taken within five days of the onset of the first symptoms for the treatment of adult patients who do not need oxygen support and are at risk of worsening the disease.
According to data released this week, the Pfizer pill is almost 90 percent effective in preventing hospitalizations and deaths in high-risk patients, and according to the latest data from laboratories, the drug remains effective against the rapidly spreading version of Omicron.
The EU is still negotiating the purchase of Merck and Pfizer drugs. It is not clear when or whether the European Commission will launch a joint procurement procedure for these drugs and how many countries will secure supplies through the European scheme or purchase them individually.
Pfizer said Tuesday it expects approval from the US Food and Drug Administration and other regulators.
The decisions come amid attempts to tackle the rise in infections in Europe, which threatens to overwhelm health systems, and amid the rapid spread of Omicron. This has prompted some governments to reintroduce restrictions ahead of the Christmas holidays, according to Reuters.
/BTA
We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!
Caretaker Prime Minister Dimitar Glavchev ordered the cancellation of the Council of Ministers' decision to establish the private Mom and Me Multiprofile Hospital for Active Treatment in Sofia, the government press service said on Saturday.
Bulgaria is set to establish its emergency air assistance service by the end of May, marking a significant step forward in the country's healthcare infrastructure
New data from the World Health Organization (WHO) underscores concerns over the global surge in antibiotic usage during the Covid-19 pandemic, potentially exacerbating the silent threat of antimicrobial resistance.
The Ministry of Health in Bulgaria has announced a significant initiative to provide free whooping cough vaccines to all pregnant women between 27 to 36 weeks of gestation
A recent UN report on the health behaviors of school-age children has unveiled concerning trends regarding alcohol and cigarette consumption among Bulgarian students, sparking widespread concern
In a recent announcement that's bound to catch attention, Bulgaria's Chief State Health Inspector, Assoc. Angel Kunchev, declared that the country will not be declaring an emergency epidemic situation due to the spread of whooping cough
UN Happiness Report: Bulgaria's Astonishing Leap in Rankings
Bulgaria: 3 Regions With Lowest Life Expectancy - EU Report 2022